                               SEQUENCE LISTING

<110> FLAGSHIP PIONEERING, INC.
 
<120> COMPOSITIONS AND METHODS FOR CELL DELIVERY

<130> 2012944-0004

<140> PCT/US2017/059610
<141> 2017-11-01

<150> 62/416,367
<151> 2016-11-02

<150> 62/416,372
<151> 2016-11-02

<150> 62/416,378
<151> 2016-11-02

<160> 34    

<170> PatentIn version 3.5

<210> 1
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Pro Phe Asp Ile Leu Tyr Gln Leu Leu Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Lys Arg Val Thr Gly Arg Pro Cys 
1               5                   


<210> 3
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Pro Phe Asp Ile Leu Tyr Gln Cys Gly Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 4
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
caacggccgg gccaaggctg tcgcaagaac                                        30


<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Pro Phe Asp Ile Leu Tyr Gln Thr Gly Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Pro Phe Asp Ile Leu Tyr Gln Thr Cys Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Pro Phe Asp Ile Leu Tyr Gln Cys Cys Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Pro Phe Asp Ile Leu Tyr Gln Gly Gly Arg Gly Gln Gly Asp Cys 
1               5                   10                  15  


<210> 9
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Pro Leu Ile Tyr Leu Arg Leu Leu Arg Gly Gln Phe 
1               5                   10          


<210> 10
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 11
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 11
Phe Gln Arg Leu Leu Arg Asn Tyr Ile Leu Pro 
1               5                   10      


<210> 12
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 12
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 13
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 13
Ile Arg Gln Leu Leu Arg Gln Phe Ser Ile Pro 
1               5                   10      


<210> 14
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 14
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 15
Tyr Lys Lys Trp Trp Arg Asn Tyr Gly Leu Pro 
1               5                   10      


<210> 16
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 17
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 17
Phe Asn Asn Trp Trp Arg Gln Phe Ser Ile Pro 
1               5                   10      


<210> 18
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 18
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 19
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Phe Gln Gly Arg Leu Leu Arg Leu Tyr Ile Leu Pro 
1               5                   10          


<210> 20
<211> 35
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 20
aagtaagtgt gccctctact ggcagcagag atcat                                  35


<210> 21
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 21
Phe Gln Arg Leu Leu Arg Asn Tyr Ile Leu Pro 
1               5                   10      


<210> 22
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 22
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 23
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 23
Ile Lys Asn Leu Leu Arg Gln Tyr Ile Leu Pro 
1               5                   10      


<210> 24
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 24
Ile Arg Gln Leu Leu Arg Gln Phe Ser Ile Pro 
1               5                   10      


<210> 25
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 25
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 26
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 26
Tyr Gln Lys Leu Leu Arg Asn Phe Ser Ile Pro 
1               5                   10      


<210> 27
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Uracil side chain

<400> 27
Tyr Lys Lys Trp Trp Arg Asn Tyr Gly Leu Pro 
1               5                   10      


<210> 28
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 28
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 29
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 29
Phe Asn Gln Trp Trp Arg Gln Tyr Gly Leu Pro 
1               5                   10      


<210> 30
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 30
Phe Asn Asn Trp Trp Arg Gln Phe Ser Ile Pro 
1               5                   10      


<210> 31
<211> 60
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 31
ggaaaaagcg gtcaactttc acgtgggcaa gttgttttac ggccacaagg tggcgcagaa       60


<210> 32
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Cytosine side chain

<400> 32
Ile Gln Arg Trp Trp Arg Asn Phe Ser Ile Pro 
1               5                   10      


<210> 33
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Leu Arg Leu Leu Arg 
1               5   


<210> 34
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 34
acggagtcaa atgggtcccg ggacac                                            26


